Skip to content

Comparison of the Guide-wire G-240 to a Combination of a Flexible/Hydrophil and a Nitinol Guide Wire

Comparison of the Use of the Guide-wire G-240 to a Combination of a Flexible/Hydrophil Guide Wire With a Nitinol Wire in Patients With Stenosis of the Bile Ducts in ERCP

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01382680
Enrollment
222
Registered
2011-06-27
Start date
2010-10-31
Completion date
2013-10-31
Last updated
2013-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Specified Diseases of Biliary Tract

Brief summary

In ERCP practice, most often a combined use of guidewires is necessary to attain a therapeutic aim. E.g. a hyperflexible hydrophilic guidewire is changed after cannulating a stricture to a nitinol wire for improved stability with the use of therapeutic devices. A new guide-wire (G240) combines these characteristics with a stable shaft and a hydrophilic tip. The investigators test the hypothesis that the use of this new guidewire would decrease number of guidewires used within one ERCP session.

Detailed description

This is a randomized, monocentric study.

Interventions

DEVICEGuidewire

Use of a guidewire at ERCP for cannulating a stenosis of the biliary tract and for applying a therapeutic device (stent, dilation catheter, others)

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data)

Exclusion criteria

* Operatively alternated anatomy of the patient. * Intervention of the pancreatic duct.

Design outcomes

Primary

MeasureTime frame
Number of guidewires per ERCP sessionWithin the same ERCP session (day 1)

Secondary

MeasureTime frameDescription
Treatment aimday 1Comparison of number of patients in whom the treatment aim could be achieved in both study groups
Time of ERCP sessionday 1Comparison of time needed for the ERCP session in both study groups.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026